# Cytokine profiles and laboratory parameters as indicators to distinguish children with PFAPA and bacterial infection

**Authors:** Xiaona Zhu, Zhi Yang, Yanyan Huang, Ying Luo, Jun Yang, Tingyan He

PMC · DOI: 10.3389/fimmu.2026.1683221 · Frontiers in Immunology · 2026-02-12

## TL;DR

This study identifies cytokine profiles and lab parameters that help distinguish PFAPA syndrome from bacterial infections in children.

## Contribution

The study introduces a diagnostic model combining IFN-γ/IL-6 ratio, IL-10, and platelet levels to improve PFAPA diagnosis.

## Key findings

- The IFN-γ/IL-6 ratio was significantly higher in PFAPA patients compared to those with bacterial infections.
- A combined model using IFN-γ/IL-6 ratio, IL-10, and platelet levels achieved high sensitivity and specificity for diagnosing PFAPA.
- The model's AUC was 0.95, indicating strong diagnostic performance.

## Abstract

Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome (PFAPA) is characterized by recurrent febrile episodes associated with one or more of the symptoms described by the acronym, and easily misdiagnosed as other infectious diseases, especially tonsillitis. We aimed to describe the clinical, laboratory parameters and cytokine profiles in patients with PFAPA and to explore indicators to distinguish children with PFAPA from bacterial infection.

Patients with PFAPA and bacterial infection, who had cytokine panels performed by Flowcytomix technique during the febrile episodes (prior to any treatments), were retrospectively enrolled from January 2020 to June 2024 in Shenzhen Children’s Hospital. Clinical data were collected from inpatient medical records. Serum levels of cytokines and other laboratory parameters were compared between patients with PFAPA and those with identified bacterial infection. Multivariate regression analysis and a receiver operating characteristic (ROC) curve analysis were performed to construct a diagnostic model to assess the potential role of serum cytokines and laboratory parameters in the diagnosis of PFAPA.

67 patients with PFAPA and 160 patients with identified bacterial infection were included in this study. The level of serum IFN-γ, and the IFN-γ/IL-6 ratio in PFAPA patients were significantly higher than those in identified bacterial infection (p < 0.0001). The cutoff value of serum IFN-γ/IL-6 ratio for differentiating PFAPA from bacterial infection was > 0.43, and the area under the receiver operating characteristic curve (AUC) was 0.79, with a sensitivity of 70.15% and a specificity of 71.88%. A diagnosis model combined IL-10, platelet and IFN-γ/IL-6 ratio was built, and the AUC was 0.95, with the sensitivity and specificity as 90.3% and 89.6%, respectively.

The IFN-γ/IL-6 ratio during febrile episodes may be useful in the early diagnosis of PFAPA by differentiating this disease from bacterial infection. The combined model based on IFN-γ/IL-6, IL-10, and PLT optimizes the diagnosis efficiency.

## Linked entities

- **Proteins:** IFNG (interferon gamma), IL6 (interleukin 6), IL10 (interleukin 10)
- **Diseases:** PFAPA (MONDO:0018540), bacterial infection (MONDO:0005113)

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, AIM2 (absent in melanoma 2) [NCBI Gene 9447] {aka PYHIN4}, SAA [NCBI Gene 6287], IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, MEFV (MEFV innate immunity regulator, pyrin) [NCBI Gene 4210] {aka FMF, MEF, PAAND, TRIM20}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, MVK (mevalonate kinase) [NCBI Gene 4598] {aka LRBP, MK, MVLK, POROK3}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132] {aka CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55}
- **Diseases:** inflammatory (MESH:D007249), hepatosplenomegaly (MESH:C535727), febrile (MESH:D000071072), streptococcal pharyngitis (MESH:D013290), rash (MESH:D005076), pneumonia (MESH:D011014), fever (MESH:D005334), pyelonephritis (MESH:D011704), Periodic fever (MESH:D056660), cervical lymphadenopathy (MESH:D002575), adenitis (MESH:D008199), bacterial co-infection (MESH:D060085), pharyngitis (MESH:D010612), arthralgia (MESH:D018771), Bacterial infection (MESH:D001424), septic (MESH:D001170), tonsillitis (MESH:D014069), bacterial bloodstream infections (MESH:D018805), infectious diseases (MESH:D003141), acute bacterial infection (MESH:D011472), PFAPA (MESH:D013281)
- **Chemicals:** PFAPA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935951/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935951/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935951/full.md

---
Source: https://tomesphere.com/paper/PMC12935951